Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.19 - $0.45 $19,304 - $45,720
-101,602 Reduced 98.02%
2,057 $0
Q1 2022

May 12, 2022

SELL
$0.36 - $0.77 $1,782 - $3,811
-4,950 Reduced 4.56%
103,659 $40,000
Q4 2021

Feb 10, 2022

BUY
$0.69 - $1.73 $3,316 - $8,316
4,807 Added 4.63%
108,609 $75,000
Q3 2021

Nov 09, 2021

SELL
$1.38 - $2.15 $3,035 - $4,730
-2,200 Reduced 2.08%
103,802 $180,000
Q2 2021

Aug 11, 2021

BUY
$1.98 - $2.74 $209,883 - $290,445
106,002 New
106,002 $231,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $348M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.